Treatment of Advanced AIDS Patients With Dextrin Sulfate

Status unconfirmed · Phase 1

Conditions studied: HIV Infections

In brief

The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in AIDS patients who have failed conventional anti-HIV treatment.

Key facts

Study ID

NCT00004987

Run by

Steinhart Medical Associates

Starts

1999-10-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this trial if they:
• Are HIV-positive.
• Have been diagnosed with AIDS and are under treatment to prevent opportunistic (AIDS-related) infection.
• Have had a CD4 cell count greater than 50 microL for at least the past 3 months.
• Have had a viral load of at least 50,000 copies/ml for at least the past 3 months.
• Have used up all other treatment options.
• Are able to understand and give written consent.

You may not qualify if…

• Patients may not be eligible for this trial if they:
• Have been in any other study in the 6 weeks before beginning this study.
• Have an active, opportunistic infection or other infection.
• Have any other long-term medical condition or nervous disorder that might make it difficult for them to finish the study.

Where it is running

• Steinhart Medical Associates — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.